In silico BRCA1 pathway analysis in breast invasive carcinoma
Recent developments in clinical patient-based personalized genomics explored a variety of biomarkers for diagnosis, prognosis, and therapy in breast invasive carcinoma (BRIC). BRCA1 mutations mediated a catastrophic situation for a damage-repairing apparatus that induced malignant transformation of...
Main Authors: | Zafar Abbas Shah, Faisal Nouroz, Asima Tayyeb |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | MGM Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.mgmjms.com/article.asp?issn=2347-7946;year=2021;volume=8;issue=1;spage=44;epage=51;aulast=Shah |
Similar Items
-
Targeting DNA Repair through Podophyllotoxin and Rutin Formulation in Hematopoietic Radioprotection: An in Silico, in Vitro, and in Vivo Study
by: M. H. Yashavarddhan, et al.
Published: (2017-10-01) -
Cell Cycle and DNA Repair Regulation in the Damage Response: Protein Phosphatases Take Over the Reins
by: Adrián Campos, et al.
Published: (2020-01-01) -
DNA Damage Stress: Cui Prodest?
by: Nagendra Verma, et al.
Published: (2019-03-01) -
BRCA1 and Its Network of Interacting Partners
by: Kyriacos Kyriacou, et al.
Published: (2013-01-01) -
Complex Mechanisms of Antimony Genotoxicity in Budding Yeast Involves Replication and Topoisomerase I-Associated DNA Lesions, Telomere Dysfunction and Inhibition of DNA Repair
by: Ireneusz Litwin, et al.
Published: (2021-04-01)